A systematic review of treatment guidelines for metastatic colorectal cancer.

Authors:
Edwards MS; Chadda SD; Zhao Z; Barber BL; Sykes DP.

Journal:
Colorectal Dis

Publication Year: 2012

DOI:
10.1111/j.1463-1318.2011.02765.x

PMCID:
PMC3562494

PMID:
21848897

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Colorectal Dis

Abbreviation: Colorectal Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A core outcome set for clinical studies of adhesive small bowel obstruction.
Tripartite Gastrointestinal Recovery SBO Group. (2022) - Transparency Score: 3/6
Acute urinary retention and urinary tract infection after short-course urinary drainage in colon or…
Venara A; Hamel JF; Régimbeau JM and 5 more (2022) - Transparency Score: 3/6
Childhood appendicitis and future risk of inflammatory bowel disease - A nationwide cohort study in…
Kiasat A; Ekström LD; Marsk R and 2 more (2022) - Transparency Score: 3/6
Colon cancer treatment in Sweden during the COVID-19 pandemic: A nationwide register-based study.
Eklöv K; Nygren J; Bringman S and 4 more (2022) - Transparency Score: 3/6
Cost of postoperative ileus following colorectal surgery: A cost analysis in the Australian public …
Traeger L; Koullouros M; Bedrikovetski S and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Funding statement: Meredith Edwards, Shkun Chadda and David Sykes are employees of PRMA Consulting and received research funding from Amgen Inc. Zhongyun Zhao and Beth Barber are employees and stockholders of Amgen Inc."

Evidence found in paper:

"Funding statement Meredith Edwards, Shkun Chadda and David Sykes are employees of PRMA Consulting and received research funding from Amgen Inc. Zhongyun Zhao and Beth Barber are employees and stockholders of Amgen Inc."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025